If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paola Cudia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

Pegoraro, V., Cudia, P., Baba, A. & Angelini, C., Jan 1 2020, (Accepted/In press) In : Neurological Sciences.

Research output: Contribution to journalArticle

  • CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy

    Böhm, J., Lornage, X., Chevessier, F., Birck, C., Zanotti, S., Cudia, P., Bulla, M., Granger, F., Bui, M. T., Sartori, M., Schneider-Gold, C., Malfatti, E., Romero, N. B., Mora, M. & Laporte, J., 2018, In : Acta Neuropathologica. 135, 1, p. 149-151 3 p.

    Research output: Contribution to journalArticle

    Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Howard, J. F., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., Jacob, S., Vissing, J., Burns, T. M., Kissel, J. T., Muppidi, S., Nowak, R. J., O'Brien, F., Wang, J. J., Mantegazza, R., Mazia, C. G., Wilken, M., Ortea, C., Saba, J., Rugiero, M. & 31 others, Bettini, M., Vidal, G., Garcia, A. D., Lamont, P., Leong, W. K., Boterhoven, H., Fyfe, B., Roberts, L., Jasinarachchi, M., Willlems, N., Wanschitz, J., Löscher, W., De Bleecker, J., Van den Abeele, G., de Koning, K., De Mey, K., Mercelis, R., Wagemaekers, L., Mahieu, D., Van Damme, P., Smetcoren, C., Bonanno, S., Antozzi, C., Maggi, L., Campanella, A., Angelini, C., Cudia, P., Pegoraro, V., Bevilacqua, F., Iorio, R. & REGAIN Study Group, Dec 1 2017, In : The Lancet Neurology. 16, 12, p. 976-986 11 p.

    Research output: Contribution to journalArticle

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Howard J.F., J., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., Jacob, S., Vissing, J., Burns, T. M., Kissel, J. T., Muppidi, S., Nowak, R. J., O'Brien, F., Wang, J-J., Mantegazza, R., Mazia, C. G., Wilken, M., Ortea, C., Saba, J., Rugiero, M. & 30 others, Bettini, M., Vidal, G., Garcia, A. D., Lamont, P., Leong, W-K., Boterhoven, H., Fyfe, B., Roberts, L., Jasinarachchi, M., Willlems, N., Wanschitz, J., Löscher, W., De Bleecker, J., Van den Abeele, G., de Koning, K., De Mey, K., Miranda, C., Bonanno, S., Antozzi, C., Maggi, L., Campanella, A., Angelini, C., Cudia, P., Pegoraro, V., Bevilacqua, F., Iorio, R., Gabriele, M., Messina, S., Amato, A. & Scala, S., 2017, In : The Lancet Neurology. 16, 12, p. 976-986 11 p.

    Research output: Contribution to journalArticle